ALT
Price
$3.52
Change
-$0.15 (-4.09%)
Updated
Aug 7 closing price
Capitalization
285.09M
4 days until earnings call
AMRN
Price
$15.10
Change
+$0.05 (+0.33%)
Updated
Aug 7 closing price
Capitalization
357.53M
Interact to see
Advertisement

ALT vs AMRN

Header iconALT vs AMRN Comparison
Open Charts ALT vs AMRNBanner chart's image
Altimmune
Price$3.52
Change-$0.15 (-4.09%)
Volume$2.43M
Capitalization285.09M
Amarin
Price$15.10
Change+$0.05 (+0.33%)
Volume$50.84K
Capitalization357.53M
ALT vs AMRN Comparison Chart in %
Loading...
ALT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
AMRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALT vs. AMRN commentary
Aug 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALT is a StrongBuy and AMRN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 08, 2025
Stock price -- (ALT: $3.52 vs. AMRN: $15.10)
Brand notoriety: ALT: Not notable vs. AMRN: Notable
ALT represents the Biotechnology, while AMRN is part of the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: ALT: 45% vs. AMRN: 40%
Market capitalization -- ALT: $285.09M vs. AMRN: $357.53M
ALT [@Biotechnology] is valued at $285.09M. AMRN’s [@Pharmaceuticals: Major] market capitalization is $357.53M. The market cap for tickers in the [@Biotechnology] industry ranges from $199.59B to $0. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Biotechnology] industry is $2.29B. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALT’s FA Score shows that 0 FA rating(s) are green whileAMRN’s FA Score has 0 green FA rating(s).

  • ALT’s FA Score: 0 green, 5 red.
  • AMRN’s FA Score: 0 green, 5 red.
According to our system of comparison, AMRN is a better buy in the long-term than ALT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALT’s TA Score shows that 5 TA indicator(s) are bullish while AMRN’s TA Score has 2 bullish TA indicator(s).

  • ALT’s TA Score: 5 bullish, 3 bearish.
  • AMRN’s TA Score: 2 bullish, 6 bearish.
According to our system of comparison, ALT is a better buy in the short-term than AMRN.

Price Growth

ALT (@Biotechnology) experienced а -4.74% price change this week, while AMRN (@Pharmaceuticals: Major) price change was +3.99% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.18%. For the same industry, the average monthly price growth was +8.39%, and the average quarterly price growth was +12.02%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was -0.43%. For the same industry, the average monthly price growth was +6.77%, and the average quarterly price growth was +13.43%.

Reported Earning Dates

ALT is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+1.18% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

@Pharmaceuticals: Major (-0.43% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AMRN($358M) has a higher market cap than ALT($285M). AMRN YTD gains are higher at: 55.670 vs. ALT (-51.248). AMRN has higher annual earnings (EBITDA): -50.7M vs. ALT (-90.75M). AMRN has more cash in the bank: 321M vs. ALT (150M). ALT has less debt than AMRN: ALT (1.59M) vs AMRN (8.74M). AMRN has higher revenues than ALT: AMRN (307M) vs ALT (20K).
ALTAMRNALT / AMRN
Capitalization285M358M80%
EBITDA-90.75M-50.7M179%
Gain YTD-51.24855.670-92%
P/E RatioN/A67.11-
Revenue20K307M0%
Total Cash150M321M47%
Total Debt1.59M8.74M18%
FUNDAMENTALS RATINGS
ALT vs AMRN: Fundamental Ratings
ALT
AMRN
OUTLOOK RATING
1..100
5465
VALUATION
overvalued / fair valued / undervalued
1..100
97
Overvalued
87
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9796
PRICE GROWTH RATING
1..100
9344
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AMRN's Valuation (87) in the Pharmaceuticals Other industry is in the same range as ALT (97) in the Miscellaneous Commercial Services industry. This means that AMRN’s stock grew similarly to ALT’s over the last 12 months.

AMRN's Profit vs Risk Rating (100) in the Pharmaceuticals Other industry is in the same range as ALT (100) in the Miscellaneous Commercial Services industry. This means that AMRN’s stock grew similarly to ALT’s over the last 12 months.

AMRN's SMR Rating (96) in the Pharmaceuticals Other industry is in the same range as ALT (97) in the Miscellaneous Commercial Services industry. This means that AMRN’s stock grew similarly to ALT’s over the last 12 months.

AMRN's Price Growth Rating (44) in the Pharmaceuticals Other industry is somewhat better than the same rating for ALT (93) in the Miscellaneous Commercial Services industry. This means that AMRN’s stock grew somewhat faster than ALT’s over the last 12 months.

AMRN's P/E Growth Rating (100) in the Pharmaceuticals Other industry is in the same range as ALT (100) in the Miscellaneous Commercial Services industry. This means that AMRN’s stock grew similarly to ALT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ALTAMRN
RSI
ODDS (%)
Bullish Trend 1 day ago
85%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
88%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
86%
MACD
ODDS (%)
Bullish Trend 1 day ago
88%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
76%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
89%
Advances
ODDS (%)
Bullish Trend 16 days ago
82%
Bullish Trend 4 days ago
73%
Declines
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 2 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 8 days ago
75%
Aroon
ODDS (%)
N/A
Bearish Trend 1 day ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
ALT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
AMRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OMMSF0.04N/A
+4.92%
Omineca Mining & Metals Ltd.
VWAGY11.090.24
+2.21%
Volkswagen AG
RXLSF30.89N/A
N/A
Rexel SA
PFLC11.45N/A
N/A
Pacific Financial Corp.
RFNDF1.17N/A
N/A
Rural Funds Group Stapled Securities

ALT and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALT has been loosely correlated with ACHV. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if ALT jumps, then ACHV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALT
1D Price
Change %
ALT100%
-4.22%
ACHV - ALT
56%
Loosely correlated
N/A
INDP - ALT
45%
Loosely correlated
-4.99%
KROS - ALT
39%
Loosely correlated
-7.29%
VKTX - ALT
38%
Loosely correlated
+11.54%
AMRN - ALT
38%
Loosely correlated
+0.33%
More

AMRN and

Correlation & Price change

A.I.dvisor indicates that over the last year, AMRN has been loosely correlated with KZR. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if AMRN jumps, then KZR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMRN
1D Price
Change %
AMRN100%
+0.33%
KZR - AMRN
56%
Loosely correlated
-2.93%
CNTB - AMRN
55%
Loosely correlated
-2.82%
HRTX - AMRN
44%
Loosely correlated
+2.21%
MGNX - AMRN
44%
Loosely correlated
N/A
ALXO - AMRN
43%
Loosely correlated
+0.54%
More